(Q80388141)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15279839%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Hitting the chemotherapy jackpot: strategy, productivity and chemistry (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15279839%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Andrew D Westwell

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15279839%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Malcolm F G Stevens

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15279839%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 August 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15279839%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15279839%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15279839%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

625-627

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15279839%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15279839%20AND%20SRC:MED&resulttype=core&format=json

Surviving the blockbuster syndrome

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903162-9

7 January 2021

Translating basic cancer research into new cancer therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903162-9

7 January 2021

Target driven chemistry in drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903162-9

7 January 2021

STI571 (Gleevec) as a paradigm for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903162-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903162-9

1 reference

7 January 2021

Rediscovering the sweet spot in drug discovery.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903162-9

7 January 2021

Drug discovery in reverse

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903162-9

7 January 2021

Obituary of Dr Paul Janssen (1926-2003).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903162-9

7 January 2021

Developmental therapeutics program at the NCI: molecular target and drug discovery process

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903162-9

7 January 2021

The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903162-9

7 January 2021

Gene expression-based high-throughput screening(GE-HTS) and application to leukemia differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903162-9

7 January 2021

10.1016/S1359-6446(04)03162-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15279839%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference